Coulter Partners places Hans T. Schambye as CEO of BOOST Pharma
LONDON, UK and COPENHAGEN, Denmark – February 24, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led the search for Hans T. Schambye, MD, PhD for his appointment to the Board of Directors at BOOST Pharma (“BOOST”), and is now pleased to announce his transition to Chief Executive Officer (CEO).